1 | 6DI5 |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
2-(4-phenoxyphenoxy)-6-[(1S,4S)-5-(prop-2-enoyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl]pyridine-3-carboxamide |
GJ7 |
|
SHOW |
2 | 4YHF |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
(2E)-2-[(E)-(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile |
4C9 |
|
SHOW |
3 | 6DI1 |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
4-amino-2-[(3S)-3-(prop-2-enamido)pyrrolidin-1-yl]pyrimidine-5-carboxamide |
GJD |
|
SHOW |
4 | 6DI3 |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
6-[(3S)-3-(acryloylamino)pyrrolidin-1-yl]-2-(4-phenoxyphenoxy)pyridine-3-carboxamide |
GJA |
|
SHOW |
5 | 6DI9 |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
6-[(3S)-3-(acryloylamino)pyrrolidin-1-yl]-2-{[4-(tert-butylcarbamoyl)phenyl]amino}pyridine-3-carboxamide |
GJJ |
|
SHOW |
6 | 6O8I |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
Branebrutinib |
LTJ |
|
SHOW |
7 | 5P9L |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
CC 292 |
7G9 |
|
SHOW |
8 | 5J87 |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
CHMFL-BTK-01 |
N42 |
|
SHOW |
9 | 5P9K |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
CNX 774 |
7G8 |
|
SHOW |
10 | 6OMU |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
Evobrutinib |
MZJ |
|
SHOW |
11 | 5P9J |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
Ibrutinib |
8E8 |
|
SHOW |
12 | 6N9P |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
N-(3-{[2-amino-3-(4-phenoxyphenyl)pyridin-4-yl]oxy}phenyl)prop-2-enamide |
KHD |
|
SHOW |
13 | 5P9M |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
Tirabrutinib |
7GB |
|
SHOW |
14 | 6J6M |
Tyrosine-protein kinase BTK |
Homo sapiens (Human) |
Q06187 |
Zanubrutinib |
BA0 |
|
SHOW |